HUMAN PLATELET ANTIGENS (HPA) - ANVISA Registration 80391910017
Access comprehensive regulatory information for HUMAN PLATELET ANTIGENS (HPA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80391910017 and manufactured by BIOARRAY SOLUTIONS LTD.. The registration is held by PH 7 COMÉRCIO E REPRESENTAÇÕES DE PRODUTOS PARA DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including PROGENIKA BIOPHARMA S.L., and 1 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80391910017
25351423634202463
59920132000184
Company Information
Dates and Status
Jan 06, 2025
VIGENTE
09/18/2025 19:00:01
HUMAN PLATELET ANTIGENS (HPA)
ID HPA XT Reagents
PROGENIKA BIOPHARMA S.L.
80134860216
Jun 20, 2016
IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS
H.P.C. – Human Platelet Concentrate
IMMUCOR, INC
10154450204
Jul 30, 2020
IMMUNOHEMATOLOGY - COMPLEMENTARY REAGENTS
PLACAS CMT
IMMUCOR, INC
10077090118
Mar 01, 2017
ANTI-PLATELET ANTIBODY
HemosIL AcuStar HIT-IgG (PF4-H)
INSTRUMENTATION LABORATORY CO.
80003610595
Nov 12, 2020
IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS
CAPTURE-P
Not specified
10077090124
Mar 01, 2017